• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Nuvalent Publishes Study on Zidesamtinib as ROS1 Inhibitor

    PR NEWSWIRE

    Nuvalent Shares Updated Data On ALK And ROS1 Inhibitors

    PR NEWSWIRE

    Nuvalent To Present ROS1 And ALK Inhibitor Data At ESMO 2024

    PR NEWSWIRE

    Nuvalent Presents New Preclinical Data of Zidesamtinib at AACR

    PR NEWSWIRE

    Nuvalent to Present New Preclinical Data on NVL-330, and zidesamtinib

    PR NEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.